TD Asset Management Inc Raises Stock Holdings in Waters Corporation $WAT

TD Asset Management Inc raised its stake in shares of Waters Corporation (NYSE:WAT) by 12.6% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 250,024 shares of the medical instruments supplier’s stock after acquiring an additional 27,990 shares during the period. TD Asset Management Inc owned approximately 0.42% of Waters worth $74,960,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in Waters by 3.3% during the third quarter. Vanguard Group Inc. now owns 7,656,891 shares of the medical instruments supplier’s stock valued at $2,295,612,000 after purchasing an additional 246,128 shares during the period. Alliancebernstein L.P. raised its stake in Waters by 31.0% during the 2nd quarter. Alliancebernstein L.P. now owns 4,021,358 shares of the medical instruments supplier’s stock valued at $1,403,615,000 after buying an additional 950,687 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Waters by 44.3% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,689,693 shares of the medical instruments supplier’s stock valued at $806,397,000 after buying an additional 825,723 shares during the period. State Street Corp boosted its stake in shares of Waters by 1.4% in the 2nd quarter. State Street Corp now owns 2,676,198 shares of the medical instruments supplier’s stock worth $934,100,000 after buying an additional 37,763 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in Waters by 2.8% during the second quarter. Geode Capital Management LLC now owns 1,552,399 shares of the medical instruments supplier’s stock valued at $539,606,000 after acquiring an additional 42,202 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Price Performance

NYSE WAT opened at $322.38 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.01 and a debt-to-equity ratio of 0.37. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15. The stock has a market cap of $19.20 billion, a price-to-earnings ratio of 29.93, a PEG ratio of 2.20 and a beta of 1.18. The company’s 50 day moving average is $369.94 and its two-hundred day moving average is $349.92.

Waters (NYSE:WAT) last announced its quarterly earnings data on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.50 by $0.03. Waters had a net margin of 20.30% and a return on equity of 34.79%. The firm had revenue of $932.36 million during the quarter, compared to analysts’ expectations of $928.17 million. During the same period in the prior year, the company posted $4.10 earnings per share. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. As a group, research analysts anticipate that Waters Corporation will post 12.86 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. William Blair began coverage on Waters in a research report on Monday, January 5th. They issued an “outperform” rating on the stock. Robert W. Baird set a $363.00 price objective on shares of Waters in a report on Tuesday, February 10th. TD Cowen restated a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. Citigroup initiated coverage on shares of Waters in a research report on Tuesday, February 10th. They issued a “buy” rating and a $425.00 price target on the stock. Finally, Evercore started coverage on shares of Waters in a research report on Tuesday, February 10th. They set a “hold” rating and a $360.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, Waters has an average rating of “Moderate Buy” and an average price target of $393.84.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.